Neurobiol Dis 38:259265 de Paula S, Vitola AS, Greggio S, de Paula D, Mello PB, Lubianca JM, Xavier LL, Fiori HH, Dacosta JC (2009) Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells
In published preclinical work, Ipamorelin stimulates growth hormone release without significantly affecting cortisol, prolactin, or aldosterone, which separates it from earlier secretagogues like GHRP-2 and GHRP-6.nnOriginally developed by Novo Nordisk in the mid-1990s as NNC 26-0161, it was studied in Phase 2 trials for postoperative ileus before that program was discontinued
Given the health benefits, carriers should be motivated
Suudhof, T